In stage III colorectal cancer, patients with higher pre-surgical levels of lymphocytes associated with cellular immunity (CD3 +, CD4+, CD8+, and CD16+) had longer survival (Milasiene, Stratilatovas & Norkiene, 2007). This evidence concerns the gene CD8A and colorectal cancer.